Quest Diagnostics Inc (DGX) stock
DGXNYSEServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 23, 2026Score 12/3011% above fair value
$262.21+2.61 (+1.01%)
Close on Nov 16, 2026Market cap $28.85BP/E 26.1Yield –
Quest Diagnostics total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Quest Diagnostics's total debt was $5.55B at Sep 30, 2026. For fiscal 2025 it was $5.67B, down 8.8% from the year before. Over ten years it grew 4.5% a year on average. The highest annual figure on record is $6.22B in fiscal 2024.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.67B | -8.8% |
| FY2024 | Dec 31, 2024 | $6.22B | +31.9% |
| FY2023 | Dec 31, 2023 | $4.71B | +18.4% |
| FY2022 | Dec 31, 2022 | $3.98B | -0.8% |
| FY2021 | Dec 31, 2021 | $4.01B | -0.1% |
| FY2020 | Dec 31, 2020 | $4.02B | -15.8% |
| FY2019 | Dec 31, 2019 | $4.77B | +22.5% |
| FY2018 | Dec 31, 2018 | $3.89B | +2.9% |
| FY2017 | Dec 31, 2017 | $3.78B | +1.3% |
| FY2016 | Dec 31, 2016 | $3.73B | +2.3% |
| FY2015 | Dec 31, 2015 | $3.65B | -2.4% |
| FY2014 | Dec 31, 2014 | $3.74B | +12.3% |
| FY2013 | Dec 31, 2013 | $3.33B | -1.0% |
| FY2012 | Dec 31, 2012 | $3.36B | -16.4% |
| FY2011 | Dec 31, 2011 | $4.02B | +34.6% |
| FY2010 | Dec 31, 2010 | $2.99B | -3.8% |
| FY2009 | Dec 31, 2009 | $3.11B | +0.8% |
| FY2008 | Dec 31, 2008 | $3.08B | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $5.55B | -2.2% |
| Q2 FY2026 | Jun 30, 2026 | $5.64B | -0.5% |
| Q1 FY2026 | Mar 31, 2026 | $5.66B | -3.4% |
| Q4 FY2025 | Dec 31, 2025 | $5.67B | -8.8% |
| Q3 FY2025 | Sep 30, 2025 | $5.68B | -9.2% |
| Q2 FY2025 | Jun 30, 2025 | $5.67B | +28.3% |
| Q1 FY2025 | Mar 31, 2025 | $5.86B | +24.4% |
| Q4 FY2024 | Dec 31, 2024 | $6.22B | +31.9% |
| Q3 FY2024 | Sep 30, 2024 | $6.25B | +47.1% |
| Q2 FY2024 | Jun 30, 2024 | $4.42B | +3.0% |
| Q1 FY2024 | Mar 31, 2024 | $4.71B | +18.4% |
| Q4 FY2023 | Dec 31, 2023 | $4.71B | +18.4% |
| Q3 FY2023 | Sep 30, 2023 | $4.25B | +6.7% |
| Q2 FY2023 | Jun 30, 2023 | $4.30B | +7.8% |
| Q1 FY2023 | Mar 31, 2023 | $3.98B | -0.3% |
| Q4 FY2022 | Dec 31, 2022 | $3.98B | -0.8% |
| Q3 FY2022 | Sep 30, 2022 | $3.98B | -0.6% |
| Q2 FY2022 | Jun 30, 2022 | $3.99B | -0.6% |
| Q1 FY2022 | Mar 31, 2022 | $3.99B | -0.6% |
| Q4 FY2021 | Dec 31, 2021 | $4.01B | -0.1% |
| Q3 FY2021 | Sep 30, 2021 | $4.01B | -12.4% |
| Q2 FY2021 | Jun 30, 2021 | $4.01B | -12.3% |
| Q1 FY2021 | Mar 31, 2021 | $4.01B | -0.6% |
| Q4 FY2020 | Dec 31, 2020 | $4.02B | -15.8% |
| Q3 FY2020 | Sep 30, 2020 | $4.57B | +14.5% |
| Q2 FY2020 | Jun 30, 2020 | $4.58B | +15.1% |
| Q1 FY2020 | Mar 31, 2020 | $4.04B | -4.8% |
| Q4 FY2019 | Dec 31, 2019 | $4.77B | +22.5% |
| Q3 FY2019 | Sep 30, 2019 | $3.99B | +8.0% |
| Q2 FY2019 | Jun 30, 2019 | $3.98B | +7.1% |
| Q1 FY2019 | Mar 31, 2019 | $4.24B | +9.8% |
| Q4 FY2018 | Dec 31, 2018 | $3.89B | +2.9% |
| Q3 FY2018 | Sep 30, 2018 | $3.70B | -1.8% |
| Q2 FY2018 | Jun 30, 2018 | $3.71B | -0.6% |
| Q1 FY2018 | Mar 31, 2018 | $3.86B | +3.4% |
| Q4 FY2017 | Dec 31, 2017 | $3.78B | +1.3% |
| Q3 FY2017 | Sep 30, 2017 | $3.76B | – |
| Q2 FY2017 | Jun 30, 2017 | $3.74B | – |
| Q1 FY2017 | Mar 31, 2017 | $3.73B | – |
| Q4 FY2016 | Dec 31, 2016 | $3.73B | – |
See a number that looks wrong?